Impact of Body Composition During Neoadjuvant Chemoradiotherapy on Complications, Survival and Tumor Response in Patients With Locally Advanced Rectal Cancer
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: To explore the impact of body composition before neoadjuvant chemoradiotherapy (pre-NCRT) and after neoadjuvant chemoradiotherapy (post-NCRT) on complications, survival, and tumor response in patients with locally advanced rectal cancer (LARC). Methods: Patients with LARC who underwent radical surgery after NCRT between Ja 22nuary 2012 and March 2019 were studied. Body composition parameters, including skeletal muscle area (SMA), muscle density (MD), visceral fat area (VFA), total abdominal fat area (TAFA), and subcutaneous fat area (SFA), was identified at the third lumbar vertebra level on computed tomography (CT). The patients were divided into two groups based on the sex-specific quartile values of SMA, MD, VFA, TAFA, SFA, and body composition change. Patient characteristics, short- and long-term postoperative complications, survival, and tumor response were analyzed. Results: A total of 122 eligible patients were enrolled. Body composition parameters, except MD, were strongly correlated with BMI (p < 0.001). Pre-NCRT low MD (p = 0.04) and TAFA loss (p = 0.02) were significantly correlated with short- and long-term ileus, respectively. Pre-NCRT low SMA was a significant prognostic factor for both disease-free survival (DFS) (HR 2.611, 95% CI 1.129–6.040, p = 0.025) and cancer-specific survival (CSS) (HR 3.124, 95% CI 1.030–9.472, p = 0.044) in the Cox regression multivariate analysis. Multivariate logistic regression analysis identified post-NCRT SFA (OR 3.425, 95% CI 1.392–8.427, p = 0.007) and SFA loss (OR 3.358, 95% CI 1.214–9.289, p = 0.02) as independent risk factors for tumor regression grade (TRG) and downstaging, respectively. Conclusion: Pre-NCRT low MD and TAFA loss were related to a high incidence of short- and long-term ileus, respectively. Pre-NCRT low SMA was a significant prognostic factor for CSS and DFS. Post-NCRT SFA and SFA loss were independent risk factors for TRG and downstaging, respectively.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“whether volumetric three-dimensional (3D) body composition adds anything over the standard two-dimensional (2D) single-slice approach in colorectal cancer (CRC) patients receiving chemoradiotherapy is unclear”
In the citing paper
“a setting in which body composition may change dynamically during treatment [24,25]”
In the citing paper
“the present data add information specific to the chemoradiotherapy setting, where body composition shifts over time [24,25,34].”
In the citing paper
“It still has advantages for tracking longitudinal change during therapy, where small shifts distributed across many slices are easier to detect [24,25,35]”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity and cancer: the role of dysfunctional adipose tissue
van Kruijsdijk, R. C. M., van der Wall, E., & Visseren, F. L. J. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0372 · Cited by 715
Kamarajah, S. K., Bundred, J., & Tan, B. H. L. (2019) · Gastric Cancer · doi:10.1007/s10120-018-0882-2 · Cited by 259
van Vugt, J. L. A., Levolger, S., Gharbharan, A., Koek, M., Niessen, W. J., Burger, J. W. A., Willemsen, S. P., de Bruin, R. W. F., & IJzermans, J. N. M. (2017) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12158 · Cited by 217
Research works printed but not linked: 38
- Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin., 68, 394, 10.3322/caac.21492 · DOI · Paper page
- Siegel, 2020, Colorectal cancer statistics, 2020, CA Cancer J Clin., 70, 145, 10.3322/caac.21601 · DOI · Paper page
- Fleshman, 2019, Disease-free survival and local recurrence for laparoscopic resection compared with open resection of stage II to III rectal cancer: follow-up results of the ACOSOG Z6051 randomized controlled trial, Ann Surg., 269, 589, 10.1097/SLA.0000000000003002 · doi:10.1097/sla.0000000000003002
- Voss, 2020, Adjuvant chemotherapy does not improve recurrence-free survival in patients with stage 2 or stage 3 rectal cancer after neoadjuvant chemoradiotherapy and total mesorectal excision, Dis Colon Rectum., 63, 427, 10.1097/DCR.0000000000001558 · DOI
- Fleming, 2011, Neoadjuvant therapy in rectal cancer, Dis Colon Rectum., 54, 901, 10.1007/DCR.0b013e31820eeb37 · DOI
- Rullier, 2010, Impact of tumor response on survival after radiochemotherapy in locally advanced rectal carcinoma, Am J Surg Pathol., 34, 562, 10.1097/PAS.0b013e3181d438b0 · DOI
- Maas, 2011, Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer, J Clin Oncol., 29, 4633, 10.1200/JCO.2011.37.7176 · DOI · Paper page
- Tobert, 2017, Emerging impact of malnutrition on surgical patients: literature review and potential implications for cystectomy in bladder cancer, J Urol., 198, 511, 10.1016/j.juro.2017.01.087 · DOI
- Marshall, 2019, Prevalence of malnutrition and impact on clinical outcomes in cancer services: a comparison of two time points, Clin Nutr., 38, 644, 10.1016/j.clnu.2018.04.007 · DOI · Paper page
- Antoun, 2010, Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma, Ann Oncol., 21, 1594, 10.1093/annonc/mdp605 · DOI · Paper page
- Lu, 2020, Preoperative fibrinogen-albumin ratio index (FARI) is a reliable prognosis and chemoradiotherapy sensitivity predictor in locally advanced rectal cancer patients undergoing radical surgery following neoadjuvant chemoradiotherapy, Cancer Manag Res., 12, 8555, 10.2147/CMAR.S273065 · DOI
- Prado, 2009, Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment, Clin Cancer Res., 15, 2920, 10.1158/1078-0432.CCR-08-2242 · DOI · Paper page
- Feliciano, 2017, Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer: results from the C SCANS Study, JAMA Oncol., 3, e172319, 10.1001/jamaoncol.2017.2319 · DOI · Paper page
- Lu, 2021, High CFP score indicates poor prognosis and chemoradiotherapy response in LARC patients, Cancer Cell Int., 21, 205, 10.1186/s12935-021-01903-1 · DOI
- Hsueh, 2019, Significance of the glasgow prognostic score in predicting the postoperative outcome of patients with stage III gastric cancer, J Clin Med, 8, 1448, 10.3390/jcm8091448 · DOI
- Almasaudi, 2020, Hypoalbuminemia reflects nutritional risk, body composition and systemic inflammation and is independently associated with survival in patients with colorectal cancer, Cancers, 12, 1986, 10.3390/cancers12071986 · DOI · Paper page
- Anandavadivelan, 2016, Cachexia in patients with oesophageal cancer, Nat Rev Clin Oncol., 13, 185, 10.1038/nrclinonc.2015.200 · DOI · Paper page
- Hotouras, 2016, The influence of obesity and body mass index on the outcome of laparoscopic colorectal surgery: a systematic literature review, Colorectal Dis., 18, O337, 10.1111/codi.13406 · DOI
- Fujiwara, 2015, Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma, J Hepatol., 63, 131, 10.1016/j.jhep.2015.02.031 · DOI · Paper page
- Bandera, 2018, Obesity, body composition, and breast cancer: an evolving science, JAMA Oncol., 4, 804, 10.1001/jamaoncol.2018.0125 · DOI
- Vrieling, 2018, Body composition in relation to clinical outcomes in renal cell cancer: a systematic review and meta-analysis, Eur Urol Focus., 4, 420, 10.1016/j.euf.2016.11.009 · DOI
- Bundred, 2019, Body composition assessment and sarcopenia in patients with pancreatic cancer: a systematic review and meta-analysis, HPB., 21, 1603, 10.1016/j.hpb.2019.05.018 · DOI
- Nattenmüller, 2019, CT-Quantified Adipose Tissue Distribution: Risk or Protective Factor for Complications after Rectal Cancer Surgery?, Obes Facts., 12, 259, 10.1159/000499320 · DOI
- Chung, 2020, Prognostic significance of sarcopenia and skeletal muscle mass change during preoperative chemoradiotherapy in locally advanced rectal cancer, Clin Nutr., 39, 820, 10.1016/j.clnu.2019.03.014 · DOI
- Miyamoto, 2015, Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer, Ann Surg Oncol., 22, 2663, 10.1245/s10434-014-4281-6 · DOI · Paper page
- Clavien, 2009, The Clavien-Dindo classification of surgical complications: five-year experience, Ann Surg., 250, 187, 10.1097/SLA.0b013e3181b13ca2 · DOI · Paper page
- Sheikhbahaei, 2021, CT-based assessment of body composition following neoadjuvant chemohormonal therapy in patients with castration-naive oligometastatic prostate cancer, Prostate., 81, 127, 10.1002/pros.24088 · DOI
- De Nardi, 2020, Changes in body composition during neoadjuvant therapy can affect prognosis in rectal cancer patients: an exploratory study, Curr Probl Cancer., 44, 100510, 10.1016/j.currproblcancer.2019.100510 · DOI · Paper page
- Xiao, 2020, Association of low muscle mass and low muscle radiodensity with morbidity and mortality for colon cancer surgery, JAMA Surg., 155, 942, 10.1001/jamasurg.2020.2497 · DOI · Paper page
- Heus, 2021, Visceral obesity and muscle mass determined by CT scan and surgical outcome in patients with advanced ovarian cancer. A retrospective cohort study, Gynecol Oncol., 160, 187, 10.1016/j.ygyno.2020.10.015 · DOI
- Choi, 2018, Sarcopenia is negatively associated with long-term outcomes in locally advanced rectal cancer, J Cachexia Sarcopenia Muscle., 9, 53, 10.1002/jcsm.12234 · DOI · Paper page
- Levolger, 2018, Muscle wasting and survival following pre-operative chemoradiotherapy for locally advanced rectal carcinoma, Clin Nutr., 37, 1728, 10.1016/j.clnu.2017.06.028 · DOI
- Baastrup, 2020, Visceral obesity and short-term outcomes after laparoscopic rectal cancer resection, Surg Endosc., 34, 177, 10.1007/s00464-019-06748-4 · DOI
- Iwase, 2021, Body composition and breast cancer risk and treatment: mechanisms and impact, Breast Cancer Res Treat., 186, 273, 10.1007/s10549-020-06092-5 · DOI
- Lin, 2021, Body composition parameters predict pathological response and outcomes in locally advanced gastric cancer after neoadjuvant treatment: a multicenter, international study, Clin Nutr., 40, 4980, 10.1016/j.clnu.2021.06.021 · DOI
- Omarini, 2019, Predictive role of body composition parameters in operable breast cancer patients treated with neoadjuvant chemotherapy, Cancer Manag Res., 11, 9563, 10.2147/CMAR.S216034 · DOI
- Shu, 2014, Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro study, BMC Cancer., 14, 566, 10.1186/1471-2407-14-566 · DOI
- Gnanendran, 2020, Acquired lipodystrophy associated with immune checkpoint inhibitors, Melanoma Res., 30, 599, 10.1097/CMR.0000000000000660 · DOI
Cited by
Chiloiro, G., Cintoni, M., Palombaro, M., Romano, A., Reina, S., Pulcini, G., Corvari, B., Di Franco, S., Meldolesi, E., Egidi, G., et al. (2024) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2024.100789 · Cited by 21
Wang, D., Sui, J., Chen, J., Chen, L., Yang, Q., Wang, Y., & Lin, S. (2026) · Healthcare · doi:10.3390/healthcare14172846
Self-citation
Metadata
- Authors
- Liu, Z., Lu, S., Wang, Y., Lin, X., Ran, P., Zhou, X., Fu, W., & Wang, H.
- Venue
- Frontiers in Nutrition
- Publisher
- Frontiers Media SA
- Published
- 2022-01-27
- Volume
- 9
- ISSN
- 2296-861X
- Cited by
- 19
- References
- 3
- Funders
- National Natural Science Foundation of China (81972702, 91959110)
- Natural Science Foundation of Beijing Municipality (7204324)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.